Skip to Main Content

Paper Details

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
Ann Oncol
1889
2015
BC, TILs, breast cancer, eosin, hematoxylin, human, human epidermal growth factor receptor 2, lymphocytic, triple-negative and human epidermal growth factor receptor 2-overexpressing BC, tumor, tumor-infiltrating lymphocytes
Author NameAffiliation
Sandra DemariaPerlmutter Cancer Center, New York University Medical School
Frederick KlauschenInstitute of Pathology, Charite -University Hospital
William F SymmansThe UT M.D. Anderson Cancer Center
Andrea L RichardsonBrigham and Women's Hospital, Dana Farber Cancer Institute
Carmen CriscitielloIstituto Europeo di Oncologia
David L RimmYale University School of Medicine
Jorge S Reis-FilhoMemorial Sloan-Kettering Cancer Center
Christos SotiriouInstitut Jules Bordet, Universite Libre de Bruxelles
  • 1 - 8

Datasets

Release 1.2